Barnsley Hospital   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Barnsley United Kingdom (1852)

Organization Overview

First Clinical Trial
2003
NCT00189878
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

sodium chloride (3 trials)

testosterone (delatestryl) (3 trials)

Drugs in Phase 2 Trials (1)

naltrexone (revia) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Hypogonadism (Phase 4)

Peripheral Arterial Disease (Phase 4)

Peripheral Vascular Diseases (Phase 4)

Urticaria (Phase 2)

Vascular Diseases (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 3